Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Redwood City, USA
3696 Haven Ave, Ste C
Redwood City, CA, 94063
USA

People

Founder & Director
Founder
President & COO
Board of Directors
Board Member
Board Member
Director
Chief Business Officer
Show All People

Funding

TOTAL $13.5M
FUNDING TOTAL $13.5M
Venture Round, 4/2013
Canaan Partners
$2M
Series A, 11/2013
$11.5M
DEBT TOTAL $4.51M
Debt, 5/2012
Correlation Ventures
Canaan Partners
$4.51M

Tags

ALDEA Pharmaceuticals

ALDEA Pharmaceuticals is developing small-molecule modulators of the aldehyde dehydrogenase enzyme (ALDH) family, to treat toxic aldehyde-related diseases. This proprietary technology represents new product opportunities to address novel targets across multiple therapeutic areas. For example, an ALDH activator compound enhances the detoxification of acetaldehyde in the alcohol metabolism pathway, to treat acute symptoms and to reduce long-term tissue damage and cancer risk.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. VC Funding: Q2 2013 source [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 11/19/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy